Dren by MHP contains the exclusive new weight loss compound, Beta-Methoxy- Phenylethylamine , a bigger and more promising breakthrough than ephedra and many individuals are comparing DREN to Clenbuterol. Scientists have been looking at the basic form Beta-Phenylethyamine (also called Beta-PEA) for years, but unfortunately its short half-life prevented this compound from ever being very effective. The first attempt to overcome the short half- life was to combine Beta-PEA with MAO inhibitors, but this also proved to be NOT effective. However, this new form isn’t just showing promise, its showing amazing results. And while Beta-Methoxy-Phenylethylamine is the new General in the war against fat a few good soldiers have been added to DREN for total annihilation of stubborn adipose FAT!
Serving Size: 1 Capsule
Servings Per Box: 30
Amount Per Serving
Mesolimbic Beta Agonist Complex:
Caffeine, L-5 Hydroxytryptophan,
Beta Methoxyphenylethylamine, and Yohimbine HCI
Other Ingredients: Yellow Opaque Gelatin Capsule, Maltodextrin, Silicon Dioxide and Magnesium Stearate.
Directions: Take 1 Capsule daily, No not exceed recommended dose
WARNING: Not intended for use by those with a medical condition. Use only as directed. Do not exceed recommended daily intake. Not intended for use by persons under age 18. Consult your physician prior to use if you are pregnant or nursing, or if you are taking medication, including but not limited to, MAO Inhibitors, antidepressants, aspirin, non-steroidal anti-inflammatory drugs or products containing ephedrine, pseudoephedrine, synephrine, phenylephrine, caffeine or other stimulants. Contains caffeine. Do not consume caffeine from other sources, including but not limited to coffee, tea, soda and other dietary supplements or medications containing caffeine.
Consult your physician prior to use if you have a medical condition, including, but not limited to, heart, kidney, liver or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headache or shortness of breath.
Do not use for more than 8 weeks.